Current advances in the clinical development of anti-tubercular agents
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current advances in the clinical development of anti-tubercular agents
Authors
Keywords
Tuberculosis, Azaindole, Benzimidazoles, Benzothiazinone, Clinical trials, Diarylquinoline, Dihydrocarbostyril, Drug resistance, Ethylenediamine, Fluoroquinolone, Imidazopyridine, Mycobacterium tuberculosis, Nitrothiazoles, Oxaboroles, Oxazolidinones, Rifamycin, Riminophenazine
Journal
TUBERCULOSIS
Volume 125, Issue -, Pages 101989
Publisher
Elsevier BV
Online
2020-09-06
DOI
10.1016/j.tube.2020.101989
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis, Structure Activity Relationship and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity
- (2020) Jessica N. Akester et al. ACS Infectious Diseases
- Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-a]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies
- (2020) Katharigatta N. Venugopala et al. Antibiotics-Basel
- Tuberculosis
- (2019) Ana M. Kelly NURSING CLINICS OF NORTH AMERICA
- Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo
- (2019) Ye Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment
- (2019) David Tenero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Structure–Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH
- (2019) Vinayak Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Treatment of Drug-Resistant Tuberculosis
- (2019) Sundari R. Mase et al. CLINICS IN CHEST MEDICINE
- In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis
- (2018) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine: A useful antibiotic for drug-resistant tuberculosis
- (2018) Reza Mirnejad et al. BIOMEDICINE & PHARMACOTHERAPY
- Delpazolid. Oxazolidinone antibiotic, Treatment of tuberculosis
- (2018) G. Kaul et al. DRUGS OF THE FUTURE
- Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
- (2018) Navisha Dookie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
- (2018) Alfred A. Lardizabal et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Global Fight Against Tuberculosis
- (2018) Charles L. Daley Thoracic Surgery Clinics
- Isoniazid derivatives and their anti-tubercular activity
- (2017) Yuan-Qiang Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses
- (2017) Faiz Ahmad Khan et al. EUROPEAN RESPIRATORY JOURNAL
- Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
- (2017) Xianfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
- (2017) Martin J Boeree et al. LANCET INFECTIOUS DISEASES
- An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial
- (2017) Tara C. Bouton et al. Trials
- Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos
- (2017) José A. Caminero et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- New agents for the treatment of drug-resistant Mycobacterium tuberculosis
- (2016) Daniel T. Hoagland et al. ADVANCED DRUG DELIVERY REVIEWS
- Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis
- (2016) Jennifer J. Furin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis
- (2016) Caroline Shi-Yan Foo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
- (2016) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
- (2016) Marina Tadolini et al. EUROPEAN RESPIRATORY JOURNAL
- To be or not to be exclusive: the sutezolid story
- (2016) Christy Wyskiel Lancet Global Health
- Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
- (2015) Norbert Heinrich et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile
- (2014) Mikhail F. Gordeev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents
- (2014) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
- (2014) Kai Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- The ongoing challenge of latent tuberculosis
- (2014) H. Esmail et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis
- (2013) Kristina Shigyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis
- (2013) V. Balasubramanian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Approval of Novel TB Drug Celebrated--With Restraint
- (2013) J. Cohen SCIENCE
- Linezolid for the treatment of drug-resistant tuberculosis in children: A review and recommendations
- (2013) Anthony J. Garcia-Prats et al. TUBERCULOSIS
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
- (2012) Katherine A Sacksteder et al. Future Microbiology
- Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children
- (2012) P. C. Rose et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis
- (2012) Dongfeng Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global tuberculosis control: lessons learnt and future prospects
- (2012) Christian Lienhardt et al. NATURE REVIEWS MICROBIOLOGY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of SQ609 as a lead compound from a library of dipiperidines
- (2011) Elena Bogatcheva et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles
- (2011) Meera Gurumurthy et al. FEBS Journal
- Nitroimidazoles for the treatment of TB: past, present and future
- (2011) Tathagata Mukherjee et al. Future Medicinal Chemistry
- The challenge of new drug discovery for tuberculosis
- (2011) Anil Koul et al. NATURE
- Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones
- (2010) M. R. Pasca et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
- (2010) V. M. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
- (2010) Robert S. Wallis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06
- (2010) H. A. Anger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hepatotoxic effects of therapies for tuberculosis
- (2010) Bahaa E. Senousy et al. Nature Reviews Gastroenterology & Hepatology
- Tuberculosis into the 2010s: Is the Glass Half Full?
- (2009) Anna P. Ralph et al. CLINICAL INFECTIOUS DISEASES
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model
- (2008) N. Lounis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning
- (2008) D. N. Wilson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started